Alnylam Drug Moves Forward at FDA

Posted by ISPE Boston
On September 14, 2023

RNAi therapeutics company Alnylam Pharmaceuticals welcomed the positive outcome of the FDA advisory committee meeting. On Wednesday the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted 9:3 that the benefits of RNAi therapeutic patisiran outweigh its risks for the treatment of the cardiomyopathy of ATTR amyloidosis. The CRDAC provides the FDA with independent, expert advice and recommendations […]

FDA Approves BioLineRx Drug for Multiple Myeloma

Posted by ISPE Boston
On September 14, 2023

Biopharma BioLineRx, headquartered in Israel with a Waltham presence, has announced FDA approval for Aphexda, the company’s first approved therapeutic. The drug helps physicians harvest stem cells for the treatment of multiple myeloma, the second most-common hematologic malignancy. Autologous stem cell transplantation (ASCT) is part of the standard of care treatment for multiple myeloma and […]

Moderna Enters New Partnership in Deal Worth Up to $1.8 Billion

Posted by ISPE Boston
On September 14, 2023

Moderna has announced it will partner with German biotech Immatics in a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high unmet medical need. This broad multi-platform collaboration will leverage the deep scientific expertise and core operational capabilities of both companies, combining Immatics’ TCR platform with Moderna’s cutting-edge […]

2023 Chapter Awards – Spotlighting Excellence in Volunteerism

Posted by ISPE Boston
On September 13, 2023

Each year the Boston Area Chapter recognizes the significant achievements of its volunteers with a family of awards designed to honor outstanding contributions. These exceptional volunteers rose to many unique challenges while adjusting to a post-pandemic world; bringing forth passion, resilience, and collaboration in order to lead the Chapter to greater heights. Thank you to […]

Jack Campion – Hank Moes Award Winner 2023!

Posted by ISPE Boston
On September 10, 2023

Jack Campion is an exceptional member of the ISPE community who has made significant contributions over the years. He has held various roles with great success, including serving as the President of the Board of Directors (2017-2018) and mentoring others. Jack’s logical, thoughtful, and intelligent approach has had a positive impact on members and volunteers […]

MassBio Reports Strong Biopharma Job Growth in 2023

Posted by ISPE Boston
On September 7, 2023

MassBio’s newly released 2023 Industry Snapshot shows significant job growth across the life sciences industry with Massachusetts outpacing nearly all competitor states for both research and development and biomanufacturing jobs added. At the close of 2022, Massachusetts employed nearly 114,000 people in the biopharma industry. “Even amidst challenging times for biotech companies, we still saw […]

Ginkgo Bioworks Partners with Google Cloud on AI for Drug Development

Posted by ISPE Boston
On September 7, 2023

Ginkgo Bioworks and Google Cloud have inked a five-year strategic cloud and AI partnership, intended to enable Ginkgo to develop and deploy AI tools for biology and biosecurity. Under the strategic partnership, Ginkgo will work to develop new, state-of-the-art large language models (LLMs) running on Google Cloud’s Vertex AI platform across genomics, protein function, and synthetic biology, helping […]

Sage Therapeutics to Implement Strategic Reorg, Reduce Staff

Posted by ISPE Boston
On September 7, 2023

Sage Therapeutics plans to reorganize its business operations and pipeline priorities to support goals for long-term business growth, including the planned commercial launch of Zurzuvae for women with postpartum depression in late 2023. Following a strategic review, the company will refine pipeline development efforts with the goal of making evidence-driven investments; implement a 40% workforce […]

Chapter Member Anniversaries: September 2023

Posted by ISPE Boston
On September 6, 2023

Please congratulate the following members celebrating milestone anniversaries in September 2023. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Edwin Harmon, PCI/ LSNE Lawrence Weiner, Enzyvant Therapeutics Jeffrey Werner, Retired Armand Mintanciyan Douglas Grevatt, Boehringer Ingelheim Pharma Gordon Brailsford, Cresa Boston Arthur Kennedy, Vernal Biosciences Alan Lam, […]

Welcome New Members August 2023!

Posted by ISPE Boston
On September 6, 2023

We would like to introduce the Members who joined ISPE in August 2023, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Page 1 of 10112 3 ›»

Blog